Drug & intervention

belinostat

RxCUI 1543543

Clinical trials6
Recruiting0
Related conditions20
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

6 shown
Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By GenomicsNCT04315233 · 2021-05-03
TERMINATED
Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian CancerNCT04703920 · 2021-03-04
COMPLETED
Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast CancerNCT03432741 · 2018-03-27
TERMINATED
A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced CancersNCT00926640 · 2009-07-01
COMPLETED
PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By SurgeryNCT00365053 · 2006-06-01
COMPLETED
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid TumorsNCT00413322 · 2005-09-01
COMPLETED

Conditions being studied

Metastatic Breast Cancer2Advanced Malignant Mesothelioma1Breast Adenocarcinoma1Carcinoma Neuroendocrine1Epithelial Mesothelioma1Malignant Epithelial Neoplasms1Metastatic Breast Carcinoma1Metastatic Castration-resistant Prostate Cancer1Metastatic Ovarian Carcinoma1Metastic or Unresectable Pancreatic Adenocarcinoma1Recurrent Breast Carcinoma1Recurrent Hodgkin Lymphoma1Recurrent Malignant Mesothelioma1Recurrent Mycosis Fungoides1Recurrent Non-Hodgkin Lymphoma1Recurrent Ovarian Carcinoma1Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma1Refractory Breast Carcinoma1Refractory Hodgkin Lymphoma1Refractory Mycosis Fungoides1

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.